Financials Scryb Inc.

Equities

SCYB

CA81111V1076

Advanced Medical Equipment & Technology

Market Closed - Canadian Securities Exchange 12:49:56 27/04/2024 am IST 5-day change 1st Jan Change
0.025 CAD 0.00% Intraday chart for Scryb Inc. -16.67% +25.00%

Valuation

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Capitalization 1 29.43 26.83 35.03 58.28 28.76 12.86
Enterprise Value (EV) 1 27.13 27.15 35.59 53.16 28.83 12.83
P/E ratio -2.88 x -3.13 x -4.41 x -2.92 x -2.58 x -0.63 x
Yield - - - - - -
Capitalization / Revenue - - - 5,02,49,131 x 4,30,08,794 x 80,74,161 x
EV / Revenue - - - 4,58,33,476 x 4,31,10,831 x 80,54,868 x
EV / EBITDA -4.02 x -5.38 x -6.2 x -4.16 x -3.14 x -0.76 x
EV / FCF -33.1 x -14.6 x -19.7 x -21.5 x -5.96 x -7.1 x
FCF Yield -3.02% -6.83% -5.07% -4.64% -16.8% -14.1%
Price to Book 4.35 x 19.1 x 40.3 x 3.44 x 3.04 x 1.5 x
Nbr of stocks (in thousands) 1,13,187 1,24,810 1,45,976 2,42,837 2,39,693 2,57,283
Reference price 2 0.2600 0.2150 0.2400 0.2400 0.1200 0.0500
Announcement Date 29/01/19 29/01/20 01/02/21 31/01/22 30/01/23 04/02/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net sales - - - 1.16 0.6688 1.593
EBITDA 1 -6.75 -5.046 -5.736 -12.77 -9.177 -16.81
EBIT 1 -7.66 -6.096 -6.029 -13.51 -9.939 -18.2
Operating Margin - - - -1,164.64% -1,486.17% -1,142.47%
Earnings before Tax (EBT) 1 -8.104 -8.091 -7.119 -17.25 -11.14 -19.77
Net income 1 -8.104 -8.02 -7.119 -17.25 -11.14 -19.77
Net margin - - - -1,487.56% -1,666.34% -1,241.09%
EPS 2 -0.0902 -0.0687 -0.0544 -0.0821 -0.0464 -0.0797
Free Cash Flow 1 -0.8192 -1.855 -1.805 -2.468 -4.835 -1.807
FCF margin - - - -212.77% -723.03% -113.41%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 29/01/19 29/01/20 01/02/21 31/01/22 30/01/23 04/02/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales 1 0.5752 0.0509 0.0579 0.0487 0.3078 0.0806
EBITDA 1 -2.715 -1.428 -1.413 -2.969 -0.8376 -6.033
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -5.864 -1.045 -2.705 -3.263 -2.243 -6.337
Net income 1 -5.864 -1.045 -2.705 -3.263 -2.243 -6.337
Net margin -1,019.62% -2,051.15% -4,670.19% -6,698.71% -728.8% -7,866.82%
EPS - - - - - -
Dividend per Share - - - - - -
Announcement Date 31/01/22 02/03/22 30/05/22 29/08/22 30/01/23 02/03/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net Debt 1 - 0.32 0.56 - 0.07 -
Net Cash position 1 2.3 - - 5.12 - 0.03
Leverage (Debt/EBITDA) - -0.0636 x -0.0972 x - -0.007436 x -
Free Cash Flow 1 -0.82 -1.85 -1.8 -2.47 -4.84 -1.81
ROE (net income / shareholders' equity) -183% -198% -624% -195% -84.7% -297%
ROA (Net income/ Total Assets) -99.8% -77.4% -140% -80.7% -42.4% -94.1%
Assets 1 8.123 10.36 5.083 21.37 26.27 21.02
Book Value Per Share 2 0.0600 0.0100 0.0100 0.0700 0.0400 0.0300
Cash Flow per Share 2 0.0200 0 0.0100 0.0200 0 0
Capex - 0.15 - 0.06 0.35 0.19
Capex / Sales - - - 5.01% 52.08% 11.87%
Announcement Date 29/01/19 29/01/20 01/02/21 31/01/22 30/01/23 04/02/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise